コンテンツへスキップ
Merck
すべての画像(1)

主要文書

AB1857

Sigma-Aldrich

Anti-Osteocalcin Antibody, a.a. 1-22

serum, Chemicon®

別名:

Anti-BGP

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12352203
eCl@ss:
32160702
NACRES:
NA.41

由来生物

rabbit

品質水準

抗体製品の状態

serum

抗体製品タイプ

primary antibodies

クローン

polyclonal

交差性

human

メーカー/製品名

Chemicon®

テクニック

ELISA: suitable
radioimmunoassay: suitable

NCBIアクセッション番号

UniProtアクセッション番号

輸送温度

wet ice

ターゲットの翻訳後修飾

unmodified

遺伝子情報

human ... BGLAP(632)

特異性

Recognizes human osteocalcin (1-22) mature form. Also reacts with osteocalcin (1-44) and osteocalcin (1-49). No reactivity with human bone sialoprotein and human osteonectin.

免疫原

Epitope: a.a. 1-22
Synthetic peptide corresponding to amino acids 1-22 of human Osteocalcin (MRALTLLALLALAALCIAGQAG).

アプリケーション

Research Category
ニューロサイエンス
Research Sub Category
ホルモン及び受容体
Anti-Osteocalcin Antibody, a.a. 1-22 detects level of Osteocalcin & has been published & validated for use in ELISA, RIA.
RIA (1:2000)

ELISA (1:5000)

Optimal working dilutions must be determined by the end user.

関連事項

Replaces: MABD182

物理的形状

Rabbit serum. Lyophilized. Reconstitute with 100 μL of sterile distillled water.

保管および安定性

Maintain lyophilized material at 2-8°C. After reconstitution maintain at -20°C in undiluted aliquots for up to 6 months. Avoid repeated freeze/thaw cycles.

法的情報

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

適切な製品が見つかりませんか。  

製品選択ツール.をお試しください

保管分類コード

10 - Combustible liquids


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Nanocomposite Ti/hydrocarbon plasma polymer films from reactive magnetron sputtering as growth support for osteoblast-like and endothelial cells.
Andrey Grinevich,Lucie Bacakova,Andrei Choukourov,Hanna Boldyryeva,Yuriy Pihosh et al.
Journal of Biomedical Materials Research Part A null
Laurent A Tchang et al.
Journal of tissue engineering and regenerative medicine, 11(5), 1542-1552 (2015-06-17)
The use of fetal bovine serum (FBS) as a culture medium supplement in cell therapy and clinical tissue engineering is challenged by immunological concerns and the risk of disease transmission. Here we tested whether human, thrombin-activated, pooled, platelet-rich plasma (tPRP)
Huawen Ding et al.
Journal of cell science, 125(Pt 22), 5564-5577 (2012-09-05)
Nitric oxide (NO) has been shown to play a crucial role in bone formation in vivo. We sought to determine the temporal effect of NO on murine embryonic stem cells (ESCs) under culture conditions that promote osteogenesis. Expression profiles of
Differentiation of mesenchymal stem cells onto highly adherent radio frequency-sputtered carbonated hydroxylapatite thin films.
Sima, Livia E, et al.
Journal of Biomedical Materials Research Part A, 95, 1203-1214 (2010)
Elena Filová et al.
International journal of nanomedicine, 9, 3687-3706 (2014-08-16)
Hydroxyapatite (HA) is considered to be a bioactive material that favorably influences the adhesion, growth, and osteogenic differentiation of osteoblasts. To optimize the cell response on the hydroxyapatite composite, it is desirable to assess the optimum concentration and also the

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)